Vaxcyte, Inc. (PCVX) Misses Q3 EPS by 32c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($1.56), $0.32 worse than the analyst estimate of ($1.24).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Piper Sandler on Chewy Inc. (CHWY): 'Increasing Focus on Share Gains'
• PennyMac Mortgage Investment Trust (PMT) PT Lowered to $10 by UBS on Lower MSR Earnings